Visits by appointment · San Carlo di Nancy · Casa di Cura Mercede · Viale Aventino practice · Rome
Urology · Urologic Oncology
Urologic Oncology
From diagnosis to oncological follow-up, a personalised treatment plan based on precision robotic surgery and up-to-date EAU guidelines.
Condition Urological tumours (prostate, kidney, bladder, testis)
Techniques Robotic · Laparoscopic · Open · Nerve-sparing · Organ-sparing
Hospital stay 2–4 days (depending on procedure)
Anaesthesia General
Follow-up Protocolled and continuous oncological follow-up
A multidisciplinary approach from day one.
Urological tumours (prostate, kidney, bladder, testis)
Treatment options
I.
Prostate Cancer
RARP
The most common male cancer in Europe. Robot-assisted radical prostatectomy is one of the options for localised disease, alongside radiotherapy and, in low-risk cases, active surveillance; the choice is made in a multidisciplinary setting.
- PSA + fusion prostate biopsy
- PET-PSMA or mpMRI staging
- Robot-assisted radical prostatectomy (RARP)
- PSA follow-up every 3 months for 2 years
Indicato per: Localised disease, surgical candidates
II.
Renal Cancer
Where possible a partial nephrectomy is performed, removing only the tumour to preserve kidney function; in small tumours it can often be done robot-assisted.
- CT/MRI with contrast for characterisation
- Robot-assisted partial nephrectomy
- Radical nephrectomy for tumours > T2
- Active surveillance for masses < 1 cm in elderly
Indicato per: Localised renal tumours, T1–T2
III.
Bladder Cancer
TURBT
Managed with endoscopic resection (TURBT) for non-muscle-invasive forms, and robot-assisted radical cystectomy with urinary diversion for advanced disease.
- TURBT + histological analysis
- Intravesical instillations (BCG / mitomycin)
- Robot-assisted radical cystectomy
- Urinary diversion: neobladder or Bricker
Indicato per: NMIBC and MIBC
Clinical pathway
-
01
First visit + second opinion
Diagnosis review, clinical documentation, options discussion. Second opinion with an in-person consultation or, for patients who live far away, online, by arrangement with the secretary's office.
-
02
Multidisciplinary team
Case discussion with medical oncologist, radiation oncologist, uropathologist and radiologist. Shared decision based on EAU guidelines.
-
03
Surgery
Robotic, laparoscopic or open approach based on staging and patient characteristics.
-
04
Post-operative care
Intensive monitoring in the first 24–72h. Complication management, discharge instructions.
-
05
Oncological follow-up
Personalised schedule: PSA, imaging, urinary cytology or cystoscopy depending on the pathology.
Frequently asked questions
What is a clinical oncological second opinion?
If you already have a diagnosis and want an independent assessment of the proposed treatment plan, you can ask for a second opinion: an in-person review consultation or, for patients who live far away, an online one, by arrangement with the secretary's office. Please bring or send all your clinical documentation.
Does localised prostate cancer always require surgery?
No. Depending on the risk profile, active surveillance, radiotherapy or surgery may all be appropriate. The decision is discussed within the multidisciplinary team.
What does nerve-sparing technique mean?
The nerve-sparing technique preserves the neurovascular bundles responsible for erectile function during radical prostatectomy. The robotic approach allows more precise dissection than open surgery, improving functional outcomes.